Picton Mahoney Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-56,583
| Closed | -$26.4M | – | 381 |
|
2020
Q4 | $26.4M | Buy |
56,583
+823
| +1% | +$383K | 1.25% | 9 |
|
2020
Q3 | $24.6M | Sell |
55,760
-8,835
| -14% | -$3.9M | 1.36% | 9 |
|
2020
Q2 | $23.4M | Buy |
64,595
+2,525
| +4% | +$915K | 1.35% | 11 |
|
2020
Q1 | $17.6M | Sell |
62,070
-170
| -0.3% | -$48.2K | 1% | 14 |
|
2019
Q4 | $20.2M | Buy |
62,240
+110
| +0.2% | +$35.7K | 1.36% | 20 |
|
2019
Q3 | $18.1M | Buy |
62,130
+8,930
| +17% | +$2.6M | 1.27% | 22 |
|
2019
Q2 | $15.6M | Buy |
+53,200
| New | +$15.6M | 1.07% | 31 |
|
2017
Q1 | – | Sell |
-93,400
| Closed | -$13.2M | – | 214 |
|
2016
Q4 | $13.2M | Sell |
93,400
-101,050
| -52% | -$14.3M | 1.08% | 32 |
|
2016
Q3 | $30.9M | Buy |
194,450
+2,050
| +1% | +$326K | 2.07% | 4 |
|
2016
Q2 | $28.4M | Sell |
192,400
-8,589
| -4% | -$1.27M | 1.75% | 9 |
|
2016
Q1 | $28.5M | Sell |
200,989
-22,711
| -10% | -$3.22M | 1.82% | 8 |
|
2015
Q4 | $31.7M | Sell |
223,700
-2,900
| -1% | -$411K | 1.9% | 8 |
|
2015
Q3 | $27.7M | Sell |
226,600
-2,200
| -1% | -$269K | 1.61% | 10 |
|
2015
Q2 | $29.7M | Buy |
228,800
+100
| +0% | +$13K | 1.46% | 7 |
|
2015
Q1 | $30.7M | Sell |
228,700
-12,000
| -5% | -$1.61M | 1.18% | 11 |
|
2014
Q4 | $30.2M | Sell |
240,700
-700
| -0.3% | -$87.7K | 1.44% | 13 |
|
2014
Q3 | $29.4K | Buy |
241,400
+10,500
| +5% | +$1.28K | 1.59% | 11 |
|
2014
Q2 | $27.2K | Sell |
230,900
-700
| -0.3% | -$83 | 1.6% | 12 |
|
2014
Q1 | $27.8M | Buy |
231,600
+68,500
| +42% | +$8.24M | 1.61% | 10 |
|
2013
Q4 | $18.2M | Sell |
163,100
-13,700
| -8% | -$1.53M | 1.06% | 22 |
|
2013
Q3 | $16.3M | Sell |
176,800
-1,800
| -1% | -$166K | 1.08% | 22 |
|
2013
Q2 | $15.1M | Buy |
+178,600
| New | +$15.1M | 1.12% | 25 |
|